BlackRock Fund Advisors’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
WP
SGA
JSP
BlackRock Fund Advisors's CLB Position: Q4 2016 in Review
BlackRock Fund Advisors increased its Core Laboratories (CLB) stake by 29% in Q4 2016, buying an estimated $5.84M and bringing the position to 233,123 shares worth $28M. The position accounts for 0.01% of the portfolio, ranked #1991.
BlackRock Fund Advisors first reported a position in CLB in Q2 2013 and has held it in 15 quarters since. The position peaked at $39M in Q1 2014. 373 funds tracked by Wall St. Rank hold CLB as of Q4 2016.
- BlackRock Fund Advisors held 233,123 shares of Core Laboratories worth $28M as of Q4 2016.
- BlackRock Fund Advisors bought 52,768 Core Laboratories shares in Q4 2016, an estimated $5.84M.
- Core Laboratories made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1991 holding.
- BlackRock Fund Advisors first reported a position in Core Laboratories in Q2 2013 and has held it in 15 quarters since.
- BlackRock Fund Advisors's Core Laboratories position peaked at $39M in Q1 2014.
- 373 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2016.
Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.